Phase III study of adjuvant gemcitabine compared with adjuvant uracil-tegafur in patients with completely resected pathological stage IB–IIIA non-small cell lung cancer (WJTOG0101)

被引：0
|
作者：
Masafumi Yamaguchi
Hirohito Tada
Tetsuya Mitsudomi
Takashi Seto
Kohei Yokoi
Nobuyuki Katakami
Kazuhiko Nakagawa
Makoto Oda
Mitsunori Ohta
Toshiyuki Sawa
Motohiro Yamashita
Norihiko Iked
Hideo Saka
Masahiko Higashiyama
Hiroaki Nomori
Hiroshi Semba
Shunichi Negoro
Yasutaka Chiba
Mototsugu Shimokawa
Masahiro Fukuoka
Yoichi Nakanishi
机构：
[1] National Hospital Organization Kyushu Cancer Center,Department of Thoracic Oncology
[2] Osaka City General Hospital,Department of Thoracic Surgery
[3] Aichi Cancer Center,Department of Thoracic Surgery
[4] Nagoya University School of Medicine,Department of Thoracic Surgery
[5] Kobe City Medical Center General Hospital,Division of Pulmonary Medicine
[6] Kinki University School of Medicine,Department of Medical Oncology
[7] Kanazawa University School of Medicine,Department of Thoracic Surgery
[8] Osaka Habikino Medical Center,Department of Thoracic Surgery
[9] Gifu Municipal Hospital,Department of Pulmonary Medicine
[10] National Hospital Organization Shikoku Cancer Center,Department of Thoracic Surgery
[11] Tokyo Medical University,Department of Surgery
[12] National Hospital Organization Nagoya Hospital,Department of Pulmonary Medicine
[13] Osaka International Cancer Institute,Department of General Thoracic Surgery
[14] Kumamoto University,Department of Thoracic Surgery, School of Medicine
[15] Kumamoto Regional Medical Center,Division of Respiratory Disease
[16] Hyogo Cancer Center,Department of Medical Oncology
[17] Kinki University School of Medicine,Division of Biostatistics, Clinical Research Center
[18] Yamaguchi University School of Medicine,Department of Biostatistics
[19] Kyushu University,Research Institute for Diseases of the Chest
来源：
International Journal of Clinical Oncology | 2021年 / 26卷
关键词：
Gemcitabine; Uracil-tegafur; Adjuvant chemotherapy; NSCLC;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：2216 / 2223
页数：7
相关论文
共 50 条
  • [1] Phase III study of adjuvant gemcitabine compared with adjuvant uracil-tegafur in patients with completely resected pathological stage IB-IIIA non-small cell lung cancer (WJTOG0101)
    Yamaguchi, Masafumi
    Tada, Hirohito
    Mitsudomi, Tetsuya
    Seto, Takashi
    Yokoi, Kohei
    Katakami, Nobuyuki
    Nakagawa, Kazuhiko
    Oda, Makoto
    Ohta, Mitsunori
    Sawa, Toshiyuki
    Yamashita, Motohiro
    Iked, Norihiko
    Saka, Hideo
    Higashiyama, Masahiko
    Nomori, Hiroaki
    Semba, Hiroshi
    Negoro, Shunichi
    Chiba, Yasutaka
    Shimokawa, Mototsugu
    Fukuoka, Masahiro
    Nakanishi, Yoichi
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2021, 26 (12) : 2216 - 2223
  • [2] Randomized Phase Ill Trial of Adjuvant Chemotherapy With Gemcitabine Compared With Oral Tegafur-uracil (UFT) in Resected, Stage IB-IIIa Non-small Cell Lung Cancer (WJTOG 0101)
    Mitsudomi, T.
    Tada, H.
    Ichinose, Y.
    Yokoi, K.
    Katakami, N.
    Oda, M.
    Negoro, S.
    Chiba, Y.
    Nakagawa, K.
    Nakanishi, Y.
    EUROPEAN JOURNAL OF CANCER, 2011, 47 : S594 - S594
  • [3] Oral uracil-tegafur compared with intravenous chemotherapy as adjuvant therapy for resected early-stage non-small cell lung cancer patients
    Liang, Sheng-Kai
    Wu, Chang-Wei
    Chang, Ching-, I
    Keng, Li-Ta
    Lee, Meng-Rui
    Wang, Jann-Yuan
    Ko, Jen-Chung
    Liao, Wei-Yu
    Chen, Kuan-Yu
    Ho, Chao-Chi
    Shih, Jin-Yuan
    Yu, Chong-Jen
    CANCER MEDICINE, 2023, 12 (17): : 17993 - 18004
  • [4] Impact of adjuvant chemotherapy in completely resected stage IIIA non-small cell lung cancer
    Naim Younes, R.
    Gross, J. L.
    Abrao, F. C.
    Rodrigues Pereira, J.
    MINERVA CHIRURGICA, 2013, 68 (02) : 169 - 174
  • [5] A multi-center phase III study of carboplatin/paclitaxel versus oral uracil-tegafur as the adjuvant chemotherapy in resected non-small cell lung cancer
    Toyooka, Shinichi
    Okumura, Norihito
    Nakamura, Hiroshige
    Nakata, Masao
    Yamashita, Motohiro
    Tada, Hirohito
    Kajiwara, Shinsuke
    Watanabe, Naoki
    Okada, Morihito
    Matsuo, Keitaro
    Aoe, Motoi
    Hotta, Katsuyuki
    Sakamoto, Junichi
    Miyoshi, Shinichiro
    Date, Hiroshi
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [6] Adjuvant Chemotherapy is Effective for Completely Resected Stage IB Non-Small Cell Lung Cancer
    Nakata, M.
    Nojima, Y.
    Nanba, K.
    Saisho, S.
    Shimizu, K.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S845 - S846
  • [7] Efficacy of Adjuvant Chemotherapy for Completely Resected Stage IB Non-Small Cell Lung Cancer
    Byun, M. K.
    Park, H. J.
    Park, H. S.
    Jeung, H.
    Cho, J. Y.
    Lee, S. S.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S1982 - S1982
  • [8] Postoperative adjuvant cisplatin, vindesine, plus uracil-tegafur chemotherapy increased survival of patients with completely resected p-stage I non-small cell lung cancer
    Imaizumi, M
    LUNG CANCER, 2005, 49 (01) : 85 - 94
  • [9] Efficacy of adjuvant chemotherapy for completely resected stage IB non-small cell lung cancer: a retrospective study
    Park, Hye Jung
    Park, Heae Surng
    Cha, Yoon Jin
    Lee, Sungsoo
    Jeung, Hei-Cheul
    Cho, Jae Yong
    Kim, Hyung Jung
    Byun, Min Kwang
    JOURNAL OF THORACIC DISEASE, 2018, 10 (04) : 2279 - 2287
  • [10] A phase II study of biweekly gemcitabine and carboplatin in completely resected stage IB-IIIA non-small cell lung cancer
    Reiko Sakurai
    Yoshio Tomizawa
    Akihiro Yoshii
    Yosuke Miura
    Hiroaki Tsurumaki
    Kyoichi Kaira
    Noriaki Sunaga
    Osamu Kawashima
    Takeshi Hisada
    Masanobu Yamada
    Ryusei Saito
    Cancer Chemotherapy and Pharmacology, 2018, 81 : 103 - 109
12345